Navigate this market better. Subscribe for FREE stock alerts and information.

Wednesday, December 17, 2014

BRIEF-Evolva sells EV-035 series to Emergent Biosolutions, (NYSE: EBS)

Evolva Holding SA : * Sells EV-035 series to emergent biosolutions* Announced that Emergent Biosolutions Inc. has acquired Evolva's anti-bacterial programme, EV-035 series* For Evolva, this transaction is worth up to $70.5 million plus royalties Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Shares of EBS traded higher by 3.02% or $0.76/share to $25.91. In the past year, the shares have traded as low as $19.31 and as high as $28.48. On average, 203356 shares of EBS exchange hands on a given day and today's volume is recorded at 286745.